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Tissue engineered skeletal muscle allows investigation of the cellular and molecular
mechanisms that regulate skeletal muscle pathology. The fabricated model must
resemble characteristics of in vivo tissue and incorporate cost-effective and high content
primary human tissue. Current models are limited by low throughput due to the
complexities associated with recruiting tissue donors, donor specific variations, as well
as cellular senescence associated with passaging. This research presents a method
using fused deposition modeling (FDM) and laser sintering (LS) 3D printing to generate
reproducible and scalable tissue engineered primary human muscle, possessing aligned
mature myotubes reminiscent of in vivo tissue. Many existing models are bespoke
causing variability when translated between laboratories. To this end, a scalable model
has been developed (25–500 µL construct volumes) allowing fabrication of mature
primary human skeletal muscle. This research provides a strategy to overcome limited
biopsy cell numbers, enabling high throughput screening of functional human tissue.
Keywords: primary skeletal muscle, tissue engineering, 3D printing, skeletal muscle physiology, bioengineering
INTRODUCTION
Physiologically representative models of skeletal muscle development, regeneration and
adaptation will underpin the next generation of understanding regarding the pathophysiological
characteristics regarding health and disease in this tissue. However, investigating the cellular and
molecularmechanisms that regulatemuscle function in vivo is problematic, with clear experimental
limitations associated with both in vivo human and animal models (Friedmann-Bette et al., 2012).
As such, establishing a highly biomimetic model that accurately represents the native in vivo
function is of paramount importance. Tissue engineering (TE) offers an alternative experimental
platform to investigate skeletal muscle development and post-natal adaptation and function.
However, many current models are not amenable to incorporation of primary human tissue, which
are often limited in experimental throughput due to the complexities associated with recruiting
tissue donors, donor specific variations, as well as cellular senescence associated with continued
passaging. Therefore, a model that is reproducible when scaling down cell number is fundamental
in generating high-powered experiments using primary human derived cells. In many current TE
skeletal muscle hydrogels, a single human microbiopsy would supply viable cells that generate∼10
constructs. The same number of cells could, however, be used to generate over 50 times this number
of constructs. Such increases would represent a significant step forward when using primary human
tissue as a cell source for the study of muscle physiology and disease in TE models.
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In vivo skeletal muscle comprises bundles of highly aligned
and differentiated post-mitotic multinucleated fibers, which are
organized in a hierarchical manner within an extracellular matrix
(ECM). When seeking to develop a TE model that is biomimetic,
it must support alignment and differentiation of seeded muscle
precursor cells (MPC’s) into multinucleated myotubes in three-
dimensions, whilst retaining the capacity to generate the force
required to perform functional contractions, representative of
those seen in vivo (Liao and Zhou, 2009). A number of
TE models have been proposed using synthetic and naturally
derived polymers. Synthetic scaffolds and molds often elicit
cellular alignment by providing topographical signals depending
on the particular manufacturing method utilized; including
electrospinning (Aviss et al., 2010) and micro-patterning (Zatti
et al., 2012) of substrates. Despite this, these scaffolds fail to
replicate the three-dimensional structure of in vivo tissue (Bian
and Bursac, 2008) and are often too stiff to facilitate MPC
differentiation (Engler et al., 2004). Therefore, naturally derived
polymers (most commonly collagen and fibrinogen) that can
be manipulated to develop three-dimensional structures are
considered more favorable due to their capacity to facilitate tissue
stiffness that physiologically resembles in vivo skeletal muscle
(Vandenburgh et al., 1988; Cheema et al., 2003; Brady et al.,
2008; Boonen et al., 2010; Vandenburgh, 2010; Hinds et al., 2011;
Langelaan et al., 2011; Truskey et al., 2013; Juhas et al., 2014;
Madden et al., 2015).
Models whereby skeletal muscle collagen based constructs
are engineered to stimulate the alignment and fusion of seeded
MPC’s along a single axis, have previously been reported
using cell sources from primary rodent (Hinds et al., 2011;
Smith et al., 2012), primary human (Powell et al., 2002;
Mudera et al., 2010; Martin et al., 2013; Madden et al., 2015),
and cell lines (Cheema et al., 2003; Gawlitta et al., 2007).
Using these cells, longitudinally orientated parallel arrays of
myotubes are evident that closely represent the in vivo fascicular
structure (Powell et al., 2002; Cheema et al., 2003; Gawlitta
et al., 2007; Hinds et al., 2011; Sharples et al., 2012; Smith
et al., 2012; Player et al., 2014). These cell laden constructs
are set between two fixed points in a mold, which provides
resistance to cell mediated contraction of the collagen matrix,
contraction of the matrix may be accompanied by a level
of collagen degradation reducing the size of the constructs,
although this does not affect the integrity of the constructs
(Grover et al., 2012). Predictable lines of longitudinal strain
are generated as the cells begin to attach (Eastwood et al.,
1996, 1998a,b) providing the mechanical stimuli required to
promote cell alignment and fusion. As a consequence, it is
possible to develop tissue that represents the morphological
structure of in vivo skeletal muscle (Smith et al., 2012). Despite
the utility of the reported models, there remains a need to
generate scaled models that can produce human skeletal muscle
constructs with reduced cell number requirements to maximize
experimental output from primary donor biopsies. Furthermore,
the molds previously utilized are typically highly bespoke in
nature, resulting in difficulties when reproducing such models
and therefore limiting the wide-ranging applicability of these
systems. Here, the creation of mold designs that are freely
available, and are accurately and instantaneously reproducible
are required.
Scaffolds that support biology have been manufactured
through a number of microfabrication processes including
chemical etching, photolithography, soft lithography, and
micromachining (Faustino et al., 2016). Many of these
microfabrication techniques involve fabricating a master or
template, typically using polydimethylsiloxane (PDMS) as the
molding material. There are many desirable properties that make
PDMS an ideal material for biological applications, including
its low cost, optical transparency, high gas permeability and
biocompatibility. However, it is known to chemically swell
in a number of solvents and will absorb many hydrophobic
compounds. These microfabrication techniques also require
the master to be chemically bonded to a second surface, a
step that often causes misalignment and poor interlaminar
adhesion. This results in labor intensive processing, requiring
specialist equipment and training, as well as the provision
of clean room facilities. Consequently, design complexity
increases manufacturing costs, making prototyping cost
and time inefficient (Capel et al., 2018). Recent advances in
three-dimensional (3D) printing technologies have allowed
the manufacture of biocompatible scaffolds that support cell
and tissue growth (An et al., 2015). 3D printing or additive
manufacturing is the established terminology describing a range
of manufacturing processes that can produce parts with complex
and highly customisable 3D geometries (Masood, 1996; Mazzoli,
2013; Skoog et al., 2014; Zhang and Zhang, 2015). In 3D printing,
parts are built layer-by-layer, using processes, such as material
extrusion, material jetting, vat photo-polymerisation, sheet
lamination, powder bed fusion, binder jetting and direct energy
deposition (Capel et al., 2013). Utilizing digitally driven printing
processes allows for the custom design and prototyping of molds
with attachments that are specific to particular tissue types, prior
to production of a final functional mold or scaffold. The rapid
and relatively inexpensive nature of 3D printing also makes such
a method suitable for laboratories to produce molds “in-house,”
rather than have to commission production from commercial
manufacturing companies.
Building on previous work in our laboratory using large
collagen hydrogels [5 and 3mL volumes (Brady et al., 2008;
Smith et al., 2012)], the present research proposes the use
of two well-established printing processes, fused deposition
modeling (FDM) and laser sintering (LS) to manufacture
scalable, reproducible and cost-effective molds. Both of these
processes have commercially available benchtop systems, capable
of manufacturing functional parts in a range of biocompatible
materials (Rimington et al., 2017, 2018). For this research, FDM
parts were printed in polylactic acid (PLA), whilst LS parts were
printed in polyamide-12 (PA-12). Both of these materials are
commercially available and suitable printing parameters are well
established amongst the literature (Capel et al., 2013; Rimington
et al., 2017). PA-12 is autoclavable making parts reusable for
culture applications, whilst the material cost of printing these
inserts in PLA (via FDM) is negligible (<£0.05 per insert) so they
can be disposed of after a single use. Here we present a rapid,
reliable and scalable method for fabricating TE primary skeletal
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muscle using 3D printed molds. Furthermore, the method
reported supports the generation of multiple construct arrays
of human derived tissue via scaled reductions in cell density.
Such constructs are capable of representing native in vivo tissue
structure and function. Crucially, the freely available designs
for commercially available instrumentation utilized in this work
will facilitate the accessible and cost-effective reproduction of
TE human skeletal muscle in vitro. All designs are available to
download at the following URL: https://figshare.com/projects/
3D_Printed_Tissue_Engineering_Scaffolds/36494.
RESULTS
3D Printed Inserts Elicit Reproducible
Extracellular Matrix Deformation in Tissue
Engineered Murine Skeletal Muscle
Measuring construct width provides an indication of cell
attachment and remodeling and as such, images of the
macroscopic contraction of the constructs were taken throughput
the culture period (Smith et al., 2012). Macroscopic analysis of
scaled constructs (Figure S1) outlined consistent remodeling
of the extracellular matrix within a scaled range of 500–25 µL
after 14 days in culture. Analysis of FDM 500 µL constructs
(https://doi.org/10.17028/rd.lboro.6969851.v1) demonstrated
potentiated early matrix remodeling after 2 days; compared to
LS 250, 100 (https://doi.org/10.17028/rd.lboro.6969806.v1) and
50 µL (https://doi.org/10.17028/rd.lboro.6969797.v1) constructs
(P = 0.015, P = 0.049, P = 0.010), 4 days culture compared to LS
50 µL (P = 0.003) and 9 days compared to LS 100 µL (P ≤ 0.05,
Figure 1). However, all LS collagen gels displayed comparable
remodeling to that of the FDM 500 µL after 14 days in culture,
despite initial reductions in deformation observed in LS
constructs (250–50 µL) across a range of time-points. Although
homogenous macroscopic reductions in 250 µL gel surface
areas were observed over time between FDM and LS processes
(https://doi.org/10.17028/rd.lboro.6969848.v1), significantly
greater matrix remodeling was evident between FDM 500 and
250 µL hydrogels after 14 days in culture (P = 0.017). This
suggested a preferential detachment of the construct matrix
from the printed molds in the larger gel volumes, facilitating an
increased rate of construct deformation.
3D Printed Inserts Promote Reproducible
Morphology Within Tissue Engineered
C2C12 Constructs Irrespective of Printing
Process or Construct Volume
Observations of the morphology of each muscle constructs
(Figure 2A) demonstrated no significant differences in nuclei
number per microscope field for cells cultured in the 500
and 250 µL FDM constructs, as well as the 100, 50 and 25
µL (https://doi.org/10.17028/rd.lboro.6969683.v1) LS constructs.
However, reduced nuclei numbers (Figure 2B) were observed
in cells cultured in the 250 µL LS constructs when compared
with the 50 (P ≤ 0.05) and 25 µL LS constructs (P ≤ 0.05).
Variations in fusion index (Figure 2C) were observed when
FIGURE 1 | (A) Macroscopic images of fused deposition modeling (FDM,
500–250 µL) and laser sintering (LS, 250–25 µL) skeletal muscle constructs
over 2, 4, 9, and 14 days culture. (B) Construct deformation analysis of entire
scaled range (500–25 µL) after 2, 4, 9, and 14 days culture. Data presented as
mean ± SD from n ≥ 3 experimental repeats in each condition. *P ≤ 0.05. For
specific mold dimensions see Table S1.
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comparing between the 500 and 250 µL FDM constructs (P
≤ 0.01), however no significant differences were observed
when comparing between any of the other conditions. Finally,
variations in myotube widths (Figure 2D) were observed when
comparing between the 500 and 250 µL FDM constructs (P
≤ 0.05), however again no significant differences in myotube
width were evident between any other conditions. The combined
morphological analyses suggest that whilst cells cultured in the
FDM 250 µL inserts exhibited reduced myotube width and
fusion index when compared with the FDM 500 µL inserts,
each of the printed inserts irrespective of printing process or
volume produced a morphologically viable, reproducible and
scalable model.
Reproducible Myotube Density and Length
Within Tissue Engineered Muscle Models
Between Construct Volumes of 500–50 µL
Myotube density, expressed as myotubes per 100µm of confocal
tile scans (Figure 3A), was reproducible between collagen
constructs of volumes from 500 and 50 µL, however statistical
differences were observed between the largest (500 µL) and
smallest (25 µL) construct volumes (P ≤ 0.05, Figure 3B).
The same trend was observed when analyzing average myotube
length within the constructs, with no observable statistical
differences between any of the construct volumes from 500
and 50 µL. Reductions in average myotube lengths were
however observed when comparing between the 500 and 25
µL constructs (P ≤ 0.05, Figure 3C). This data again indicates
that these constructs enable the generation of reproducible and
scalable collagen skeletal muscle constructs down to the size
of 50 µL.
Addition of Matrigel® Matrix to Tissue
Engineered Muscle Models Elicits
Increased Myotube Density and Myoblast
Fusion
Having established scalability within the model, 50 µL constructs
(https://doi.org/10.17028/rd.lboro.6969710.v1) were selected as
a suitable construct size and cell seeding number (2 × 105
cells per construct). Whilst LS has been demonstrated as a
viable manufacturing option, reduced print material cost (∼£30
vs. ∼£200 per kg), machine cost (<£1 k vs. >£100 k) and
consequently availability, as well as the necessity to post-
process LS parts to remove non-sintered PA-12 particles from
the molds, all made FDM the more favorable print process
for this application. As such, molds were re-designed to
incorporate a removable chamber (https://doi.org/10.17028/rd.
lboro.6969707.v1, Figure S1) preventing any unwanted adhesion
between the matrix and the molds; making FDM a viable
manufacturing process at the required scale. Furthermore,
the inclusion of Matrigel R©; containing basement membrane
proteins, into the model increased the biological relevance of the
hydrogel composition. In vivomuscle fibers are encased within a
basement membrane containing a range of pericellular proteins.
This close association of sarcolemma and basement membrane
creates an important biological niche in which satellite cells,
the stem cells of muscle, reside. Morphological comparisons
between C2C12 muscle constructs demonstrated significant (P
≤ 0.001) increases in myotube density (expressed as myotubes
per 100µm) for constructs containing Matrigel R© matrix (65%
type 1 rat tail collagen, 20% Matrigel R©), when compared
to constructs manufactured from only collagen (85% type 1
rat tail collagen). Likewise, constructs containing Matrigel R©
demonstrated increased myoblast fusion (P ≤ 0.0005) when
compared with the collagen only gels. No significant differences
were observed between the two construct types when assessing
average myotube widths (P ≥ 0.05). Reproducible construct
deformation was observed across construct types indicating
homogeneous C2C12 re-modeling of the extracellular matrix
regardless of matrix composition. Muscle function within the
Matrigel R© constructs was assessed through the production of
contractile force when exposed to electrical field stimulation at 1,
5, and 100Hz (Figure 4), exhibiting significantly enhanced force
compared to collagen only matrices. This stimulation generated
an average maximal twitch force of 48.39 ± 3.49 µN, as well
as an average maximal tetanic force of 47.74 ± 0.31 µN. Force
generated signifies an increase in construct maturation compared
to collagen only hydrogels at both 65 (4.87, 6.02 µN) and
85% (4.16, 5.98 µN) matrix composition for twitch and tetanus
contractions respectively (Figure S2).
Functional Tissue Engineered Human
Derived Skeletal Muscle Constructs (50 µL,
2 × 105 Cells Per Construct)
Morphological analysis between donors demonstrated no
significant variations in average myotube density (expressed
as myotubes per 100µm), fusion index or average myotube
length (all P ≥ 0.05), representing a reproducible morphological
response within the model regardless of the HDMC source.
Likewise, construct deformation for both donors was
reproducible, indicating homogeneous remodeling of the
extracellular matrix. Muscle function within the HDMC
constructs was assessed through the production of contractile
force when exposed to electrical field stimulation at 1 and 100Hz.
This stimulation generated an average maximal twitch force of
30.45 ± 7.86 µN for donor 1 and 41.52 ± 8.38 µN for donor 2,
as well as an average maximal tetanic force of 57.07µN for donor
1 and 36.96± 7.04 µN for donor 2 (Figure 5).
DISCUSSION
Establishing a model that closely represents native in vivo
skeletal muscle is of paramount importance if such in vitro
systems are to have utility in understanding the physiology
of skeletal muscle development, as well as the underpinning
mechanisms associated with health and disease within this tissue.
Furthermore, it is essential that where appropriate primary
human tissue is utilized, due to the issues associated with accurate
translation of in vitro cell line and in vivo animal data to human
clinical trials. However, obtaining large numbers of myogenic
cells from human biopsies is experimentally laborious, time
consuming and presents challenges associated with maintaining
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FIGURE 2 | (A) Morphological staining of the actin cytoskeleton (red) and nucleic DNA (blue) for each of the C2C12 muscle constructs after 14 days in culture.
(B) Average nuclei number per microscope field for each of the C2C12 muscle constructs after 14 days in culture. (C) Fusion index for each of the C2C12 muscle
constructs after 14 days in culture. (D) Average myotube width for each of the C2C12 muscle constructs after 14 days in culture. Data presented as mean ± SD from
n ≥ 3 experimental repeats in each condition. *P ≤ 0.05, **P ≤ 0.01. Scale bar = 50 µm.
cellular phenotype across serial passages. Attempts have been
made to extend the number of passages tolerated by primary
skeletal muscle cells (Penton et al., 2016), however, when using
primary human cells reducing the number of cells required per
experiment is still paramount to increasing throughput. Other
potential applications of tissue engineered muscle, including
transplantation of large tissue volumes, may necessitate the use
of constructs of varying size and cell number, and as such
for these models to have a significant impact in the basic and
applied sciences, it is essential they are time and cost efficient to
produce, facilitate scalability and allow flexibility of application.
Here we have presented a rapid, reliable and scalable model
which produces TE human skeletal muscle within a modified
type-1 collagen hydrogel that closely represents the structure
and function of native in vivo tissue. The model presented
in this research provides the first viable and morphologically
mature TE primary skeletal muscle model, generated using
commercially available 3D printing and open access designs,
allowing accurate translation of results between laboratories. The
scaling work presented (≥1 × 105 cells per construct) facilitates
the generation ofmultiple constructs per donor biopsy enhancing
experimental throughput.
Type-1 collagen is present in the epi-, peri-, and endomysial
layers of skeletal muscle (Kjaer, 2004), with this extracellular
protein being extensively used in the generation of hydrogel-
based skeletal muscle that is highly organized in nature
(Cheema et al., 2003; Vandenburgh, 2010; Hinds et al., 2011).
These systems are considered more favorable than conventional
monolayer cultures of myotubes (early pre-mature muscle
fibers), owing to the in vivo-like alignment, the enhanced
experimental longevity and the organization of myotubes in
three dimensions (Vandenburgh et al., 1988). Most models share
the same basic principle of hydrogel attachment to anchor
materials that act as pseudo-tendons, to provide the mechanical
signal required for cell alignment and differentiation. This has
previously been achieved through the use of multiple materials
including; polyethylene meshwork (Brady et al., 2008; Mudera
et al., 2010; Player et al., 2014), Velcro R© tabs (Boonen et al., 2010;
Langelaan et al., 2011) and polydimethylsiloxane (PDMS) posts
(Vandenburgh, 2010). Advancements in additive manufacture
(AM) have prompted a trend toward TE platforms (Truskey et al.,
2013) that are manufactured by automated technology (Costa
et al., 2015; Zhang and Zhang, 2015), due to the associated design
flexibility of processes, such as 3D printing. The model presented
here, demonstrates the use of biocompatible PLA and PA-12
(Rimington et al., 2017, 2018) molds building on previously
published molds that feature a twin or single based post design
at decreasing construct volumes, utilizing user-friendly accessible
FDM and LS 3D printing techniques (Jones et al., 2018).
Such designs ensure there is minimal friction between the side
surfaces of the constructs; eliciting cell-mediated mechanical
matrix contraction in the X axis that facilitates myoblast
alignment and myogenic differentiation for the formation of 3D
multinucleated myotubes.
Deformation analysis of scaled constructs appeared to
indicate favorable matrix contraction of FDM 500 µL hydrogels
across early time-points. However, such discrepancies were
largely negated after 14 days in culture in scaled FDM and
LS constructs; indicating comparable cellular attachment and
mechanical contraction independent of polymer or construct
volume. Such responses may allude to a non-significant
effect of polymer/matrix interaction when scaling 3D printed
collagen gel constructs. It was observed that complete matrix
detachment from the mold material surrounding the construct
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FIGURE 3 | (A) Morphological staining of the actin cytoskeleton (red) and nucleic DNA (blue) for each of the constructs after 14 days in culture. Images captured via
confocal tile scan (Zeiss LSM 880) and stitched together enabling visualization of the whole construct. (B) Myotube density within the collagen construct, expresses as
myotubes per 100µm, for each of the muscle constructs after 14 days in culture. (C) Average myotube length for each of the muscle constructs after 14 days in
culture. Data presented as mean ± SD from n ≥ 3 experimental repeats in each condition. *P ≤ 0.05. Scale bar = 100µm.
posts facilitated complete matrix deformation, ensuring
uniaxial cell-mediated matrix contraction in the Y axis and
preventing conflicting strain in the X axis. The probability
of incomplete matrix detachment appeared to increase with
reducing construct volume, necessitating the development
of the two-part construct design with a removable barrier
(Figures S1E,I), ensuring complete matrix detachment from the
mold after 48 h (Figure 4A).
Comparisons of morphological measures (nuclei number,
myotube fusion index, myotube width and length, and myotube
density) across each of the scaled volumes were highly
reproducible. Although reduced fusion efficiency and myotube
widths were observed within FDM 250 µL constructs, hydrogels
still evidenced viable morphological development. In addition,
reductions in this scaled range were offset by comparable
myotube fusion index and width observed in LS 250 µL
constructs. When assessing all morphological measures as
one body of evidence the experimental procedure utilized
provides a robust and reproducible model, irrespective of
manufacturing process or construct volume. The manufacturing
process of choice is therefore a selection between the inexpensive,
disposable FDM molds or the more expensive but autoclavable
PA-12 LS molds. Further examination of entire scaled collagen
constructs (FDM; 500 µL, LS; 250–25 µL), utilizing confocal tile
stitching to create “macroscopic” images of microscopic cellular
regions (Figure 3) further outlined effective, reproducible scaling
of in vivo-like skeletal muscle. Differences in length, and density
of myotube distribution were evident in LS 25 µL constructs
compared to FDM 500 µL. However, such differences may be a
consequence of the advanced biomimetic environment observed
within FDM 500 µL constructs; entailing densely packed aligned
myotubes of up to 1mm in length with abundant sarcomeric
organization. As such, although it is reasonable to suggest that
viable cultures of multinucleated myotubes remained evident
within this scaled volume, it is recommended that scaling within
the current model be refined to the range of 500–50 µL volumes.
To further assist AM technique selection to replicate designs
within this work, a comprehensive summary figure detailing
the steps of manufacture and their specific advantages for
tissue engineering applications is provided in the supplementary
information section (Table S2).
Addition of 20% v/v Matrigel R© matrix to TE C2C12 muscle
models was shown to significantly increase morphological
(myotube density and fusion index) and functional (force
output, Figure S2) measures of tissue maturation, whilst also
maintaining uniform cell-mediated matrix remodeling as in
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FIGURE 4 | Morphological staining of the actin cytoskeleton (red) and nucleic DNA (blue) for collagen only and collagen/Matrigel® C2C12 muscle constructs after 14
days in culture. Images captured via confocal tile scan (Zeiss LSM 880) and stitched together enabling visualization of the whole construct. (A) Macroscopic images
and construct deformation analysis of C2C12 muscle constructs after 2, 4, 9, and 14 days culture, for collagen only and collagen/Matrigel
® constructs. (B) Contractile
force measurements for collagen/Matrigel® C2C12 muscle constructs exposed to electrical field stimulation at 1, 5, and 100Hz. (C) Average maximal twitch force and
maximal tetanic force measurements for collagen/Matrigel® C2C12 muscle constructs exposed to electrical field stimulation. (D) Myotube density within the collagen
only and collagen/Matrigel® C2C12 muscle constructs, expressed as myotubes per 100µm, for each constructs after 14 days in culture. (E) Average myotube width
for each of the C2C12 muscle constructs after 14 days in culture. (F) Myotube fusion index for each of the C2C12 muscle constructs after 14 days in culture. Data
presented as mean ± SD from n ≥ 3 experimental repeats in each condition. ***P ≤ 0.001. Scale bar = 100µm for main body stained images, 50µm for inset
stained images, 100ms for B.
the collagen only constructs (Figure 4). Specifically, collagen-
Matrigel R© constructs were shown to exhibit a 3-fold increase
in myotubes per 100µm (2.74 ± 0.71 vs. 0.90 ± 0.18), as
well as substantially increased fusion index (56.62 ± 10.86 vs.
35.81 ± 10.46%) when compared to the collagen only models.
Both average myotube width and construct deformation were
consistent across both conditions. The scalability of the model
(>1 × 105 cells per model) would also enable primary HDMC
constructs to be realized in quantities suitable for substantial
experimental and biological repeats from each muscle donor
(up to 500). These HDMC constructs demonstrated the same
abundance of aligned multinucleated myotubes as the C2C12 cell
line models, as well as exhibiting muscular striation indicative
of mature tissue (Figure 5). This maturation was confirmed
morphologically with average myotube widths in excess of
24µm, myotube densities in excess of 1.4 myotubes per 100µm,
as well as fusion index values in excess of 35% for both
donors. Functional contractile force measurements in response
to electrical field stimulation generated twitch force in excess of
30 µN (1Hz), as well as maximal tetanic forces in excess of 36
µN (100Hz) for both donors. The tetanic force traces generated
also demonstrated the capacity of these constructs to contract
and relax in response to electrical excitation, mimicking the
behavior of in vivo tissue (Figure 5). In addition to the generation
of highly mature primary human muscle tissue, the addition
of Matrigel R© matrix supplemented the model with basement
membrane proteins, increasing biomimicry within the system.
This has been previously reported in fibrinogen/Matrigel R©
constructs, in which additive addition of the basementmembrane
component resulted in enhanced tissue maturation (Hinds et al.,
2011). The precise composition of these matrix components can
have a profound effect upon the biophysical and biochemical
interactions that regulate biological behavior within the tissue.
For example, it is known that matrix elasticity and hydrogel
stiffness (elastic modulus) within both synthetic and naturally
derived polymer scaffolds can direct stem cell differentiation
(Engler et al., 2006), regulate cellular migration, spreading and
adhesion (Pelham and Wang, 1997; Zaman et al., 2006; Olsen
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FIGURE 5 | (a,b) Morphological staining of the actin cytoskeleton (red) and nucleic DNA (blue) for human derived muscle cell constructs from donor 1 and donor 2
after 14 days in culture, as well as macroscopic images of construct deformation over 2, 4, 9, and 14 days culture. Images captured via confocal tile scan (Zeiss LSM
880) and stitched enabling visualization of the whole construct. (c) Morphological staining of the muscle specific protein filament Myosin Heavy Chain (green) and
nucleic DNA (blue) on histological cross-section. (d) Myotube density within the collagen/Matrigel® human derived muscle cell constructs, expressed as myotubes
per 100 µm, for each constructs after 14 days in culture. (e) Myotube fusion index within the collagen/Matrigel® human derived muscle cell constructs, expressed as
myotubes per 100 µm, for each constructs after 14 days in culture. (f) Average myotube length within the collagen/Matrigel® human derived muscle cell constructs,
expressed as myotubes per 100 µm, for each constructs after 14 days in culture. (g) Construct deformation analysis of collagen/Matrigel® human derived muscle cell
constructs after 2, 4, 9, and 14 days culture. (h) Representative tetanic and twitch contractile force measurements for human derived muscle cell constructs.
(i) Average maximal twitch force and maximal tetanic force measurements for human derived muscle cell constructs exposed to electrical field stimulation. Data
presented as mean ± SD from n ≥ 3 experimental repeats in each condition. **P ≤ 0.01. Scale bar = 100 µm for tile scan images (top), 50 µm for individual stained
images (middle), 100 ms for f.
et al., 2011) and specifically within tissue engineered muscle
will modulate force production (Hinds et al., 2011). Collagen-1
hydrogels of concentration 1, 3, and 7mg/mL have been recorded
with elastic modulus of 5.0± 0.6, 55.4± 11.0, and 341.8± 32.4 Pa
(Slater et al., 2017). Materials characterization of high collagen
(4mg/mL), collagen/Matrigel R© (2/2 mg/mL) and collagen/ high
Matrigel R© (2/4 mg/mL) compositions has also been documented
(Anguiano et al., 2017) with increases in fiber diameter and
pore size observed with the addition of Matrigel R©. It should be
noted that Matrigel R© supplement is an animal derived basement
membrane extract (secreted by Engelbreth-Holm-Swarm mouse
sarcoma cells), and as such may exhibit variability between
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commercial suppliers and batches. As such it is critical that
experimentation using this supplement is highly controlled, with
controls and experimental conditions derived from single batches
to ensure variability does not confound results.
Precision scaling of bioengineered skeletal muscle presented
within this work across a range of 500–50 µL constructs, allows
for the generation of both cell line and primary tissues that can
be used in high content experimental screening prior to larger
scale in vitro and small animal in vivo studies (Vandenburgh,
2010). Moreover, it is possible to generate multiple analytical;
molecular (gene expression), morphological (histology) and
functional (force generation) data from the presented constructs,
demonstrating its diverse utility during biological investigations.
The scalability of the model presented makes it highly suited
to using primary MPC derived from multiple species. This
work builds on the previous human TE models previously
produced (Powell et al., 2002; Mudera et al., 2010; Martin et al.,
2013; Madden et al., 2015), however significantly reduces the
cell seeding density required to produce densely packed and
functionally mature tissues. Previous models utilizing sutra pins
and fibrinogen matrixes have reported seeding numbers as low
as 1 × 105, however viable tissue was only established at 4 × 105
densities (Martin et al., 2013). Bespoke systems using fibrinogen
(Madden et al., 2015) and type-1 collagen (Powell et al., 2002),
both combined with Matrigel R© required seeding densities of
7.5 × 105 and 1.2 × 106 cells per mold respectively. The
seeding density for scaled constructs reported in this work would
elicit a 50% decrease in the cell number required to produce
mature tissue, when compared to the lowest viable density
previously reported. Furthermore, the bespoke nature of many
of the previously published systems elicits issues in experimental
scale up. This significantly enhances the amount of tissue
producible from each donor biopsy, while also satisfying the
3R’s principles of biological research (Replacement, Refinement,
and Reduction). Should primary animal cells be used, the
models presented here enhance the number of constructs and
experiments (repeated measures) that can be conducted using
tissue isolated from a single donor animal.
Current and future work surrounding skeletal muscle will
focus on the successful integration of supporting cells types.
Here, the ability to design and, crucially, adapt biocompatible 3D
printed constructs to facilitate the development of the desired
biological microenvironment will be of paramount importance.
As such, the adoption of methods that incorporate the flexibility
and rapid prototyping capability of 3D printing demonstrated
within this work will contribute significantly to the advancement
of skeletal muscle and provide concepts which can apply to other
engineered tissues in the future.
MATERIALS AND METHODS
Design and Fabrication of 3D Printed
Well-Insert Molds
3D printing was performed either by FDM or LS. Molds were
designed with a single or twin post fixed at the end of a
rectangular mold (Figure S1). Mold and post dimensions were
scaled to match the volume of collagen required for each specific
construct (Table S1). 50 µL constructs were assembled in 2-
parts with a removable barrier. The external geometries of
the part were designed to fit into a standard 6 or 12 well
culture plate. All 3D modeling was performed using computer
aided design (CAD) Siemens NX software (version 8.5); with
completed.stl files verified using Materialize MiniMagics. FDM
printing utilized a commercially available Ultimaker 2+ system
(Ultimaker, Netherlands). For FDM, completed.stl files were
processed using the in-house Cura Software for Ultimaker 2+
(version 3.2). FDM parts were printed using PLA and were
extruded onto the standard glass build plate, at previously
published settings (Rimington et al., 2017). LS parts were
printed using an EOS Formiga P100TM (EOS GmbH, Germany)
from PA-12. The powder used was a mixture of recycled
and virgin powder (20% recycled, 80% virgin); well within
manufacturer recommendations. Samples were removed from
the build chamber and cleaned using a soft abrasive brush to
remove un-sintered powder. All samples were sterilized via UV
for ≥1 h, prior to being adhered to culture well plates using an
in-house bio-adhesive which has been found to be completely
compatible (Rimington et al., 2017). Once adhered, samples
were rinsed with 70% IMS and left for the remaining solvent to
evaporate prior to use.
Cell Culture
Culture of C2C12 Skeletal Muscle Myoblast Cells
C2C12 skeletal muscle myoblast cells (ECACC, all below
passage 10) were grown using standard growth medium (GM);
composed of Dulbecco’s Modified Eagle’s Medium (DMEM,
Fisher–Scientific, UK), 20% fetal bovine serum (FBS, Pan Biotech,
UK), and, 1% Penicillin/Steptomyocin (P/S, Fisher–Scientific,
UK). Cells were cultured in T80 flasks (NuncTM, Fisher–Scientific,
UK) and incubated in a 5% CO2 humidified atmosphere at 37
◦C
until 80% confluence was attained. GM was changed every 24 h
during the culture period for expansion of cells.
Isolation and Subsequent Culture of Human Derived
Muscle Cells (HDMCs)
Healthy males volunteered for this study, which was approved
by the Loughborough University Ethics Approvals (Human
Participants) Sub Committee (reference number: H14-P16).
Before participation, subjects provided written informed consent
and completed a medical screening questionnaire. HDMC
samples were obtained from healthy males (n = 2), between
the ages of 18–55 reporting no recent injuries or intake of
anti-inflammatory pharmaceuticals. Tissue was obtained via the
Bergstrom biopsy procedure, with any visible connective tissue
being removed (Bergstrom, 1975). Tissue samples were removed
from the storage GM solution and washed three times in a
buffer solution (PBS, 1% P/S & 1% Amphotericin, Sigma, UK).
Once washed tissue chunks were placed into a petri dish,
suspended in 1mL of GM and mechanically minced using 2
scalpel blades until broken down into small sized pieces. Tissue
was then seeded into 0.2% gelatin (Sigma, UK) coated T25
flasks (approximately 4 pieces/flask) and suspended in 0.5mL
of GM to ensure tissue was planted on the culture surface
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and not floating. Flasks were then placed in standard tissue
culture incubators (37◦C humidified atmosphere/5% CO2) for
7–10 days to allow cellular migration to occur with more GM
added to prevent flasks drying out. Migration of HDMC’s was
monitored with the migrated cellular population passaged at
60% confluence to prevent spontaneous differentiation at low
passage. Cells were dissociated with accutase (Fisher-Scientific,
UK) before re-plating. HDMC’s were then cultured through
three passages to confirm myogenic capacity and increase cell
quantity for experimental purposes. All HDMC’s were used
between passages 3 and 6 as previously published by our group
(Martin et al., 2013).
Tissue Engineered Constructs
Collagen constructs were generated using C2C12 myoblasts,
with the method based around previous work from our group
(Mudera et al., 2010). Collagen hydrogels were formed by
the addition of 85% v/v type I rat tail collagen (First Link,
UK; dissolved in 0.1M acetic acid, protein at 2.035mg per
mL), with 10% v/v of 10X minimal essential medium (MEM)
(Gibco, UK). This solution was subsequently neutralized by the
addition of 5 and 1M sodium hydroxide (NaOH) dropwise,
until a color change to cirrus pink was observed. The cells
were added at a seeding density of 4 × 106 cells per mL in
a 5% v/v GM solution, before being transferred to the pre-
sterilized inserts (various construct sizes, Figure 1) to set for 10–
15min at 37 ◦C. GM was added for 4 days and changed daily,
before being changed to differentiation media (DM, DMEM, 2%
Horse Serum (HS), 1% P/S) for a further 10 days in culture.
Collagen/Matrigel R© constructs were generated using both C2C12
myoblasts (Figure 4) and HDMCs (Figure 5) in removable 50
µL molds (Figure S1) 3D printed via FDM. Gels were formed
by the addition of 65% v/v type I rat tail collagen, with 10%
v/v of 10X minimal essential medium (MEM) (Gibco, UK). This
solution was subsequently neutralized by the addition of 5 and
1M sodium hydroxide (NaOH) dropwise, until a color change to
cirrus pink was observed. This was followed by the addition of
20% v/v Corning R© Matrigel R© Matrix (Corning, Germany). The
cells were added at a seeding density of 4 × 106 cells per mL in a
5% v/v GM solution, before being transferred to the pre-sterilized
inserts to set for 10–15min in an incubator. GM was added for 4
days and changed daily, before being changed to DM for a further
10 days in culture. Figure 6 outlines the process for fabricating
tissue engineered skeletal muscle.
Cryosectioning
Fixed constructs were dehydrated in 10% (24 h) sucrose followed
by 20% (24 h) sucrose (w/v in Tris-buffered saline (TBS).
FIGURE 6 | Schematic diagram for tissue engineered skeletal muscle fabrication.
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Constructs were then embedded in Tissue-Tek R© (VWR, USA)
optimum cutting temperature (O.C.T) mounting medium and
frozen at −80◦C for a minimum of 2 h. Once frozen 12µm
sections were prepared, using standard cryostat protocols,
perpendicular to the longitudinal axis of the construct.
Immunohistochemistry
Following the 14 days culture period, constructs were fixed using
methanol and acetone at increasing concentrations. For C2C12
and HDMC constructs, the actin cytoskeleton was identified
using Rhodamine-Phalloidin (1:500, Thermo-Fisher, UK) and
nuclei were stained using DAPI (1:2,000, Thermo-Fisher, UK)
in Tris-Buffered Saline (TBS) for 2 h. Slides were then washed
(3 × 15min, TBS) and transferred to poly-lysine microscope
slides (Thermo-Fisher, UK) and mounted using FluoromountTM
mounting medium (Sigma-Aldrich, UK). For cryosections of
HDMC constructs, sections were stained for Desmin to show
myogenic cells and DAPI. Briefly sections were incubated
overnight with anti-desmin antibody (1:200, Dako, UK, clone
D33) in blocking solution (Tris-buffered saline mixed with
polysorbate 20, TBST, 5% Goat serum). Samples were washed
(3 × 15min, TBS) and incubated for 1 h with secondary
fluorescent antibody (1:500, Invitrogen, UK, Alexa FluorTM 588
goat anti-mouse) and DAPI (1:2,000) in blocking solution.
Slides were then washed (3 × 15min, TBS) and mounted as
previously described.
Analytical Procedures
Measuring construct width provides an indication of cell
attachment and remodeling and as such, images of the
macroscopic contraction of the constructs were taken throughput
the culture period using an EPSON flatbed scanner [Perfection
V330 Photo, 300DPI, (Smith et al., 2012)]. Construct width
was measured using FIJI image analysis software [version 1.5a,
(Schindelin et al., 2012)]. Images were captured using a Leica
DM2500 or a Zeiss LSM 880 confocal and used to analyse
the morphology of the myotubes including; fusion efficiency
(number of nuclei in myotubes represented as a percentage of the
total number of nuclei in the image frame), myotube density per
100µm (number of myotubes measured across a 100µm cross
section of the gel), myotube length and myotube width. Analysis
was conducted from 5 images taken from each construct, within
each condition and repeated at least three times (n ≥ 3).
Assessment of Muscle Function by
Electrical Stimulation
Constructs were washed twice in PBS and one end of the
construct was removed from the mold. The loose end of the
construct was then attached to the force transducer (403A
Aurora force transducer, Aurora Scientific, UK) using the
eyelet present in the construct. The construct was covered
(3mL) with Krebs-Ringer-HEPES buffer solution (KRH; 10mM
HEPES, 138mM NaCl, 4.7mM KCl, 1.25mM CaCl2, 1.25mM
MgSO, 5mM Glucose, 0.05% Bovine Serum Albumin in dH20,
Sigma, UK). Wire electrodes were positioned either side of
the construct to allow for electric field stimulation. Impulses
were generated using LabVIEW software (National Instruments,
Berkshire, United Kingdom) connected to a custom-built
amplifier. Maximal twitch force was determined using a single 3.6
v/mm, 1.2ms impulse and maximal tetanic force was measured
using a 1 s pulse train at 100Hz and 3.6 v/mm, generated
using LabVIEW 2012 software (National Instruments, UK).
Where possible, twitch and tetanus data were derived from three
contractions per construct. Data was acquired using a Powerlab
system (ver. 8/35) and associated software (Labchart 8, AD
Instruments, UK).
Statistical Analysis
Significance of data were determined using IBM© SPSS©
Statistics version 23. Mauchly’s test of sphericity and Shapiro-
Wilk tests were used to confirm homogeneity of variance and
normal distribution of data, respectively. Where parametric
assumptions were met, a 4 × 6 (Figure 1), 2 × 5 (Figure 4),
or 2 × 4 (Figure 5) factorial analysis of variance (ANOVA)
was used for construct deformation analyses. One-way ANOVA
(1 × 4) was used to analyse morphological data; myotube
number, myotube width, fusion index, nuclei number, myotube
density, and myotube length only concerned with experimental
termination time-points. Where significant interactions were
observed, Bonferroni post-hoc analyses were used to analyse
differences between conditions at specific time-points. Non-
parametric Kruskal-Wallis (H) analysis was undertaken where
data violated parametric assumptions. Mann-Whitney (U) tests
were then utilized to determine significance between conditions,
in accordance with Bonferroni correction to account for
incremental type-1 error. All data is reported as mean± standard
deviation (SD). Significance was assumed at P ≤ 0.05.
LIST OF AVAILABLE DESIGNS USED
WITHIN THIS WORK
500 µL Mold FDM—Available online at: https://doi.org/10.
17028/rd.lboro.6969851.v1.
250 µL Mold FDM and LS—Available online at: https://doi.
org/10.17028/rd.lboro.6969848.v1.
100 µL Mold LS—Available online at: https://doi.org/10.
17028/rd.lboro.6969806.v1.
50µLMold LS—Available online at: https://doi.org/10.17028/
rd.lboro.6969797.v1.
50 µL Mold FDM—Available online at: https://doi.org/10.
17028/rd.lboro.6969710.v1.
50µL FDM removable insert—Available online at: https://doi.
org/10.17028/rd.lboro.6969707.v1.
25µLMold LS—Available online at: https://doi.org/10.17028/
rd.lboro.6969683.v1.
AUTHOR CONTRIBUTIONS
Design and 3D printing were conducted by AC and RR. Primary
human biopsies were conducted by RF. Primary human tissue
explant was conducted by NM. AC, RR, JF, DP, NM, JJ, and MT
designed and conducted biological experiments. AC, RR, JF, MT,
and LB contributed to analytical work. AC, RR, JF, and DP wrote
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 11 February 2019 | Volume 7 | Article 20
Capel et al. Human Tissue Engineered Skeletal Muscle
the manuscript. VM andML conceived the concept and reviewed
the manuscript.
ACKNOWLEDGMENTS
The authors would like to acknowledge Loughborough
University, EPSRC (grant reference EP/L02067X/1) for funding
and support for this work. In addition, this research was funded
by the NIHR Leicester Biomedical Research Centre. The views
expressed are those of the author(s) and not necessarily those
of the NHS, the National Institute for Health Research or the
Department of Health. Authors acknowledge that part of the
introductory text from this article is also used to introduce the
Open Access published designs listed in this work on figshare at
the following URL: https://figshare.com/projects/3D_Printed_
Tissue_Engineering_Scaffolds/36494.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fbioe.
2019.00020/full#supplementary-material
REFERENCES
An, J., Teoh, J. E. M., Suntornnond, R., and Chua, C. K. (2015). Design
and 3D printing of scaffolds and tissues. Engineering 1, 261–268.
doi: 10.15302/J-ENG-2015061
Anguiano, M., Castilla, C., Maška, M., Ederra, C., Peláez, R., Morales, X., et al.
(2017). Characterization of three-dimensional cancer cell migration in mixed
collagen-Matrigel scaffolds using microfluidics and image analysis. PLoS ONE
12:e0171417. doi: 10.1371/journal.pone.0171417
Aviss, K. J., Gough, J. E., and Downes, S. (2010). Aligned electrospun polymer
fibres for skeletal muscle regeneration. Eur. Cell. Mater. 19, 193–204.
doi: 10.22203/eCM.v019a19
Bergstrom, J. (1975). Percutaneous needle biopsy of skeletal muscle in
physiological and clinical research. Scand. J. Clin. Lab. Invest. 35, 609–616.
doi: 10.3109/00365517509095787
Bian, W., and Bursac, N. (2008). Tissue engineering of functional skeletal muscle:
challenges and recent advances. IEEE Eng. Med. Biol. Mag. 27, 109–113.
doi: 10.1109/MEMB.2008.928460
Boonen, K. J. M., Langelaan, M. L. P., Polak, R. B., van der Schaft,
D. W. J., Baaijens, F. P. T., and Post, M. J. (2010). Effects of a
combined mechanical stimulation protocol: value for skeletal muscle
tissue engineering. J. Biomech. 43, 1514–1521. doi: 10.1016/j.jbiomech.2010.
01.039
Brady, M. A., Lewis, M. P., and Mudera, V. (2008). Synergy between myogenic
and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle
construct. J. Tissue Eng. Regen. Med. 2, 408–417. doi: 10.1002/term.112
Capel, A. J., Edmondson, S., Christie, S. D. R., Goodridge, R. D., Bibb, R. J., and
Thurstans, M. (2013). Design and additive manufacture for flow chemistry. Lab
Chip 13, 4583–4590. doi: 10.1039/c3lc50844g
Capel, A. J., Rimington, R. P., Lewis, M. P., and Christie, S. D. R. (2018). 3D
printing for chemical, pharmaceutical and biological applications. Nat. Rev.
Chem. 2, 422–436. doi: 10.1038/s41570-018-0058-y
Cheema, U., Yang, S.-Y., Mudera, V., Goldspink, G. G., and Brown, R. A. (2003). 3-
D in vitromodel of early skeletal muscle development. Cell Motil. Cytoskeleton
54, 226–236. doi: 10.1002/cm.10095
Costa, P. F., Hutmacher, D. W., Theodoropoulos, C., Gomes, M. E., Reis, R. L.,
and Vaquette, C. (2015). Additivelymanufactured device for dynamic culture of
large arrays of 3D tissue engineered constructs.Adv. Healthc.Mater. 4, 864–873.
doi: 10.1002/adhm.201400591
Eastwood, M., McGrouther, D. A., and Brown, R. A. (1998a). Fibroblast responses
to mechanical forces. Proc. Inst. Mech. Eng. H. 212, 85–92.
Eastwood, M., Mudera, V. C., McGrouther, D. A., and Brown, R. A. (1998b).
Effect of precise mechanical loading on fibroblast populated collagen lattices:
Morphological changes. Cell Motil. Cytoskeleton 40, 13–21.
Eastwood, M., Porter, R., Khan, U., McGrouther, G., and Brown, R. (1996).
Quantitative analysis of collagen gel contractile forces generated by dermal
fibroblasts and the relationship to cell morphology. J. Cell. Physiol. 166, 33–42.
Engler, A. J., Griffin,M. A., Sen, S., Bönnemann, C. G., Sweeney, H. L., and Discher,
D. E. (2004). Myotubes differentiate optimally on substrates with tissue-like
stiffness: pathological implications for soft or stiff microenvironments. J. Cell
Biol. 166, 877–887. doi: 10.1083/jcb.200405004
Engler, A. J., Sen, S., Sweeney, H. L., and Discher, D. E. (2006). Matrix
elasticity directs stem cell lineage specification. Cell 126, 677–689.
doi: 10.1016/j.cell.2006.06.044
Faustino, V., Catarino, S. O., Lima, R., and Minas, G. (2016). Biomedical
microfluidic devices by using low-cost fabrication techniques: a review. J.
Biomech. 49, 2280–2292. doi: 10.1016/j.jbiomech.2015.11.031
Friedmann-Bette, B., Schwartz, F. R., Eckhardt, H., Billeter, R., Bonaterra, G., and
Kinscherf, R. (2012). Similar changes of gene expression in human skeletal
muscle after resistance exercise and multiple fine needle biopsies. J. Appl.
Physiol. 112, 289–295. doi: 10.1152/japplphysiol.00959.2011
Gawlitta, D., Oomens, C. W. J., Bader, D. L., Baaijens, F. P. T., and Bouten, C.
V. C. (2007). Temporal differences in the influence of ischemic factors and
deformation on the metabolism of engineered skeletal muscle. J. Appl. Physiol.
103, 464–473. doi: 10.1152/japplphysiol.01374.2006
Grover, C. N., Cameron, R. E., and Best, S. M. (2012). Investigating the
morphological, mechanical and degradation properties of scaffolds comprising
collagen, gelatin and elastin for use in soft tissue engineering. J. Mech. Behav.
Biomed. Mater. 10, 62–74. doi: 10.1016/j.jmbbm.2012.02.028
Hinds, S., Bian, W., Dennis, R. G., and Bursac, N. (2011). The role of extracellular
matrix composition in structure and function of bioengineered skeletal muscle.
Biomaterials 32, 3575–3583. doi: 10.1016/j.biomaterials.2011.01.062
Jones, J. M., Player, D. J., Martin, N. R. W., Capel, A. J., Lewis, M.
P., and Mudera, V. (2018). An assessment of myotube morphology,
matrix deformation, and myogenic mRNA expression in custom-built and
commercially available engineered muscle chamber configurations. Front.
Physiol. 9:483. doi: 10.3389/fphys.2018.00483
Juhas, M., Engelmayr, G. C., Fontanella, A. N., Palmer, G. M., and Bursac, N.
(2014). Biomimetic engineered muscle with capacity for vascular integration
and functional maturation in vivo. Proc. Natl. Acad. Sci. U.S.A. 111, 5508–5513.
doi: 10.1073/pnas.1402723111
Kjaer, M. (2004). Role of extracellular matrix in adaptation of tendon
and skeletal muscle to mechanical loading. Physiol. Rev. 84, 649–698.
doi: 10.1152/physrev.00031.2003
Langelaan, M. L. P., Boonen, K. J. M., Rosaria-Chak, K. Y., van der Schaft, D. W. J.,
Post, M. J., and Baaijens, F. P. T. (2011). Advanced maturation by electrical
stimulation: Differences in response between C2C12 and primary muscle
progenitor cells. J. Tissue Eng. Regen. Med. 5, 529–539. doi: 10.1002/term.345
Liao, H., and Zhou, G.-Q. (2009). Development and progress of engineering
of skeletal muscle tissue. Tissue Eng. Part B. Rev. 15, 319–331.
doi: 10.1089/ten.teb.2009.0092
Madden, L., Juhas, M., Kraus, W. E., Truskey, G. A., and Bursac, N. (2015).
Bioengineered human myobundles mimic clinical responses of skeletal muscle
to drugs. Elife 4:e04885. doi: 10.7554/eLife.04885
Martin, N. R. W., Passey, S. L., Player, D. J., Khodabukus, A., Ferguson, R. A.,
Sharples, A. P., et al. (2013). Factors affecting the structure and maturation
of human tissue engineered skeletal muscle. Biomaterials 34, 5759–5765.
doi: 10.1016/j.biomaterials.2013.04.002
Masood, S. H. (1996). Intelligent rapid prototyping with fused deposition
modelling. Rapid Prototyp. J. 2, 24–33. doi: 10.1108/13552549610109054
Mazzoli, A. (2013). Selective laser sintering in biomedical engineering. Med. Biol.
Eng. Comput. 51, 245–256. doi: 10.1007/s11517-012-1001-x
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 12 February 2019 | Volume 7 | Article 20
Capel et al. Human Tissue Engineered Skeletal Muscle
Mudera, V., Smith, A. S. T., Brady, M. A., and Lewis, M. P. (2010). The effect of cell
density on the maturation and contractile ability of muscle derived cells in a 3D
tissue-engineered skeletal muscle model and determination of the cellular and
mechanical stimuli required for the synthesis of a postural phenotype. J. Cell.
Physiol. 225, 646–653. doi: 10.1002/jcp.22271
Olsen, A. L., Bloomer, S. A., Chan, E. P., Gaça, M. D. A., Georges, P. C.,
Sackey, B., et al. (2011). Hepatic stellate cells require a stiff environment for
myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 301,
G110–G118. doi: 10.1152/ajpgi.00412.2010
Pelham, R. J., and Wang, Y. I. (1997). Cell locomotion and focal adhesions are
regulated by substrate flexibility. Proc. Natl. Acad. Sci. U.S.A. 94, 13661–13665.
doi: 10.1073/pnas.94.25.13661
Penton, C. M., Badarinarayana, V., Prisco, J., Powers, E., Pincus, M., Allen, R. E.,
et al. (2016). Laminin 521 maintains differentiation potential of mouse and
human satellite cell-derived myoblasts during long-term culture expansion.
Skelet. Muscle 6, 1–16. doi: 10.1186/s13395-016-0116-4
Player, D. J., Martin, N. R. W., Passey, S. L., Sharples, A. P., Mudera, V., and
Lewis, M. P. (2014). Acute mechanical overload increases IGF-I and MMP-9
mRNA in 3D tissue-engineered skeletal muscle. Biotechnol. Lett. 36, 1113–1124.
doi: 10.1007/s10529-014-1464-y
Powell, C. A., Smiley, B. L., Mills, J., and Vandenburgh, H. H. (2002). Mechanical
stimulation improves tissue-engineered human skeletal muscle. Am. J. Physiol.
Cell Physiol. 283, C1557–C1565. doi: 10.1152/ajpcell.00595.2001
Rimington, R. P., Capel, A. J., Christie, S. D. R., and Lewis, M. P.
(2017). Biocompatible 3D printed polymers via fused deposition modelling
direct C2C12 cellular phenotype in vitro. Lab Chip 17, 2982–2993.
doi: 10.1039/C7LC00577F
Rimington, R. P., Capel, A. J., Player, D. J., Bibb, R. J., Christie, S. D. R., and Lewis,
M. P. (2018). Feasibility and biocompatibility of 3D-printed photopolymerized
and laser sintered polymers for neuronal, myogenic, and hepatic cell types.
Macromol. Biosci. 18:e1800113. doi: 10.1002/mabi.201800113
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T.,
et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat.
Methods 9, 676–682. doi: 10.1038/nmeth.2019
Sharples, A. P., Player, D. J., Martin, N. R. W., Mudera, V., Stewart, C. E.,
and Lewis, M. P. (2012). Modelling in vivo skeletal muscle ageing in vitro
using three-dimensional bioengineered constructs. Aging Cell 11, 986–995.
doi: 10.1111/j.1474-9726.2012.00869.x
Skoog, S. A., Goering, P. L., and Narayan, R. J. (2014). Stereolithography
in tissue engineering. J. Mater. Sci. Mater. Med. 25, 845–856.
doi: 10.1007/s10856-013-5107-y
Slater, K., Partridge, J., and Nadivada, H. (2017). Tuning the Elastic Moduli
of Corning R© Matrigel R© and Collagen I 3D Matrices by Varying the Protein
Concentration. Corning. Available online at: https://www.corning.com/media/
worldwide/cls/documents/applications/CLS-AC-AN-449 DL.pdf
Smith, A. S. T., Passey, S., Greensmith, L., Mudera, V., and Lewis, M. P. (2012).
Characterization and optimization of a simple, repeatable system for the
long term in vitro culture of aligned myotubes in 3D. J. Cell. Biochem. 113,
1044–1053. doi: 10.1002/jcb.23437
Truskey, G. A., Achneck, H. E., Bursac, N., Chan, H., Cheng, C. S., Fernandez, C.,
et al. (2013). Design considerations for an integratedmicrophysiological muscle
tissue for drug and tissue toxicity testing. Stem Cell Res. Ther. 4 (Suppl. 1):S10.
doi: 10.1186/scrt371
Vandenburgh, H. (2010). High-content drug screening with engineered
musculoskeletal tissues. Tissue Eng. Part B. Rev. 16, 55–64.
doi: 10.1089/ten.teb.2009.0445
Vandenburgh, H. H., Karlisch, P., and Farr, L. (1988). Maintenance of highly
contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell.
Dev. Biol. 24, 166–74.
Zaman, M. H., Trapani, L. M., Sieminski, A. L., Siemeski, A., Mackellar,
D., Gong, H., et al. (2006). Migration of tumor cells in 3D matrices is
governed by matrix stiffness along with cell-matrix adhesion and proteolysis.
Proc. Natl. Acad. Sci. U.S.A. 103, 10889–10894. doi: 10.1073/pnas.06044
60103
Zatti, S., Zoso, A., Serena, E., Luni, C., Cimetta, E., and Elvassore, N. (2012).
Micropatterning topology on soft substrates affects myoblast proliferation and
differentiation. Langmuir 28, 2718–2726. doi: 10.1021/la204776e
Zhang, X., and Zhang, Y. (2015). Tissue engineering applications of
three-dimensional bioprinting. Cell Biochem. Biophys. 72, 777–782.
doi: 10.1007/s12013-015-0531-x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Capel, Rimington, Fleming, Player, Baker, Turner, Jones, Martin,
Ferguson, Mudera and Lewis. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 13 February 2019 | Volume 7 | Article 20
